【Healthkoreanews】"Radiation plus hormone therapy can lower the probablity of prostate cancer deaths.", said a new survey by a Swedish research team.
In the survey, 875 men with locally advanced prostate cancer were randomly assigned to receive either the drug flutamide (Eulexin), to block androgens (male hormones), or hormone therapy along with radiation. Androgens are thought to encourage the spread of prostate cancer.
Over an average follow-up of almost 8 years, 79 men who received hormone treatment alone died, compared with 37 men who received hormone treatment plus radiation.
After 10 years, 23.9 % of the men in the hormone therapy-only group had died from prostate cancer compared with 11.9 % of the men in the combined treatment group. In addition, death from any cause was higher in the hormone therapy-only group (39.4%) than in the combined treatment group (29.6%).
Moreover, fewer men in the combined treatment group saw a return of their cancer (26%) than did men in the hormone therapy-only group (75%).<헬스코리아뉴스>
